rs200163795

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2

The NM_004959.5(NR5A1):​c.368G>C​(p.Gly123Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,612,350 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G123W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

NR5A1
NM_004959.5 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:3

Conservation

PhyloP100: 2.07

Publications

11 publications found
Variant links:
Genes affected
NR5A1 (HGNC:7983): (nuclear receptor subfamily 5 group A member 1) The protein encoded by this gene is a transcriptional activator involved in sex determination. The encoded protein binds DNA as a monomer. Defects in this gene are a cause of XY sex reversal with or without adrenal failure as well as adrenocortical insufficiency without ovarian defect. [provided by RefSeq, Jul 2008]
NR5A1 Gene-Disease associations (from GenCC):
  • 46,XX sex reversal 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • 46,XY sex reversal 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • premature ovarian failure 7
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • 46 XX gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XX ovotesticular disorder of sex development
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XX sex reversal 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XY complete gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 46 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Gene score misZ: 2.3359 (below the threshold of 3.09). Trascript score misZ: 2.4094 (below the threshold of 3.09). GenCC associations: The gene is linked to 46,XY sex reversal 3, 46,XX sex reversal 4, 46,XX ovotesticular disorder of sex development, premature ovarian failure 7, spermatogenic failure 8, 46,XY partial gonadal dysgenesis, 46 XX gonadal dysgenesis, male infertility with azoospermia or oligozoospermia due to single gene mutation, 46,XX sex reversal 1, 46,XY complete gonadal dysgenesis.
BP4
Computational evidence support a benign effect (MetaRNN=0.067549795).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00086 (131/152328) while in subpopulation AFR AF = 0.00274 (114/41582). AF 95% confidence interval is 0.00233. There are 0 homozygotes in GnomAd4. There are 65 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 131 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR5A1NM_004959.5 linkc.368G>C p.Gly123Ala missense_variant Exon 4 of 7 ENST00000373588.9 NP_004950.2 Q13285F1D8R8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR5A1ENST00000373588.9 linkc.368G>C p.Gly123Ala missense_variant Exon 4 of 7 1 NM_004959.5 ENSP00000362690.4 Q13285
NR5A1ENST00000620110.4 linkc.368G>C p.Gly123Ala missense_variant Exon 4 of 6 5 ENSP00000483309.1 F1DAM0
NR5A1ENST00000455734.1 linkc.368G>C p.Gly123Ala missense_variant Exon 4 of 4 3 ENSP00000393245.1 Q5T6F6
NR5A1ENST00000373587.3 linkc.40-320G>C intron_variant Intron 1 of 4 3 ENSP00000362689.3 Q5T6F7

Frequencies

GnomAD3 genomes
AF:
0.000848
AC:
129
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00273
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000232
AC:
56
AN:
241878
AF XY:
0.000151
show subpopulations
Gnomad AFR exome
AF:
0.00281
Gnomad AMR exome
AF:
0.000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000279
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.000105
AC:
154
AN:
1460022
Hom.:
1
Cov.:
32
AF XY:
0.0000881
AC XY:
64
AN XY:
726288
show subpopulations
African (AFR)
AF:
0.00293
AC:
98
AN:
33468
American (AMR)
AF:
0.000447
AC:
20
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51790
Middle Eastern (MID)
AF:
0.000352
AC:
2
AN:
5674
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1111958
Other (OTH)
AF:
0.000365
AC:
22
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000860
AC:
131
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.000873
AC XY:
65
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00274
AC:
114
AN:
41582
American (AMR)
AF:
0.000849
AC:
13
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000208
Hom.:
0
Bravo
AF:
0.00124
ESP6500AA
AF:
0.00327
AC:
14
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000281
AC:
34
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Spermatogenic failure 8 Pathogenic:1
-
Clinical Cytology, Cytogenetics, Reproductive Biology and Human Development Laboratory, Cheikh Anta Diop University
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Uncertain:1
May 04, 2022
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 11, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23543655, 32242295, 20887963, 31787151) -

Oligosynaptic infertility;C2751824:46,XY disorder of sex development Benign:1
Jan 16, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NR5A1-related disorder Benign:1
Feb 09, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
15
DANN
Benign
0.72
DEOGEN2
Benign
0.41
.;T;.
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.85
T;T;T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.068
T;T;T
MetaSVM
Benign
-0.36
T
MutationAssessor
Benign
1.5
.;L;.
PhyloP100
2.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.2
.;N;N
REVEL
Benign
0.15
Sift
Benign
0.58
.;T;T
Sift4G
Benign
0.35
T;T;.
Polyphen
0.0010
.;B;.
Vest4
0.23
MVP
0.57
MPC
0.82
ClinPred
0.0071
T
GERP RS
2.5
PromoterAI
0.029
Neutral
Varity_R
0.062
gMVP
0.48
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200163795; hg19: chr9-127262871; API